# STEM CELL THERAPEUTICS CORP — Form D

STEM CELL THERAPEUTICS CORP of Toronto, A6, a company, filed a Form D exempt-offering notice with the SEC on 2013-12-23. The offering totals $60.7M, of which $30.3M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2013-12-23
- Form: D
- Accession: 0001140361-13-047323
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $60.7M
- Amount sold: $30.3M
- Remaining: $30.4M
- Investors: 22
- Date of first sale: 2013-12-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-208615

## Issuer

- Name: STEM CELL THERAPEUTICS CORP
- CIK: 0001392333
- Entity type: Corporation
- Jurisdiction: ONTARIO, CANADA
- Address: 96 Skyway Avenue, Toronto, A6, M9W 4Y9
- Phone: 416-457-4670

## Officers, directors & promoters (11)

| Name | Role | Location |
| --- | --- | --- |
| David Geoffrey Peter Allan | Director | Toronto, A6 |
| James Michael DeMesa | Director | Toronto, A6 |
| Henry G Friesen | Director | Toronto, A6 |
| Michael G Moore | Director | Toronto, A6 |
| Ronald Dean Peterson | Director | Toronto, A6 |
| Niclas Stiernholm | Director | Mississauga, A6 |
| Calvin Ralph Stiller | Director | Toronto, A6 |
| James Todd Parsons | Executive Officer | Toronto, A6 |
| Penka Petrova | Executive Officer | Mississauga, A6 |
| Niclas Stiernholm | Executive Officer | Mississauga, A6 |
| Robert Uger | Executive Officer | Mississauga, A6 |

## More

- [CIK 1392333 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1392333&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001140361-13-047323.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.